Cite
HARVARD Citation
Ljubenkov, P. et al. (n.d.). A phase 1b, randomized, double‐blind, placebo‐controlled, parallel cohort safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy study of intravenously infused BIIB092 in patients with four different primary tauopathy syndromes. Alzheimer's & dementia. p. n/a. [Online].